Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 61 - 80
of 218
Sort by Relevance
|
Sort by Date
6 Jan 2017, 6:28 am
Merrell Dow Pharmaceuticals,Inc., 509 U.S. 579 (1993). [read post]
2 Dec 2016, 9:35 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
1 Nov 2016, 8:27 pm
Merrell Dow Pharmaceuticals must be satisfied for a class to be certified under Federal Rule of Civil Procedure 23 when challenged expert testimony is at issue, particularly in light of this court leaving issues open in Tyson Foods, Inc. v. [read post]
31 Oct 2016, 7:18 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the United States Supreme Court replaced the old Frye test for determining the admissibility of expert evidence with the new Daubert, pursuant to which judges serve as gatekeepers and... [read post]
6 Apr 2016, 12:06 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
31 Mar 2016, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
31 Mar 2016, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
31 Mar 2016, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
22 Oct 2015, 1:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), you must object to an expert, such as a doctor, when his testimony does not comply with Fla. [read post]
17 Oct 2015, 5:29 am
” Earp v. [read post]
25 Aug 2015, 8:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
28 Jul 2015, 11:52 am
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
14 Jul 2015, 6:41 am
Merrell Dow Pharmaceuticals, Inc., the landmark case that sets forth the test for the admissibility of expert testimony. [read post]
1 Jul 2015, 7:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and related cases.[6]” The court in Ladd Furniture v. [read post]
16 Jun 2015, 7:22 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993) (specifying the “the known or potential rate of error” as one of several factors in assessing the scientific reliability or validity of proffered expert witness’s opinion) Kumho Tire Co. v. [read post]
9 Jun 2015, 5:54 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), and (3) the testimony assists the trier of fact through the application of scientific, technical, or other specialized expertise. [read post]
28 May 2015, 2:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993). [read post]
14 May 2015, 2:15 pm
Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease. [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
3 Jan 2015, 3:47 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
